Novo Nordisk

Latest stories

6d
Business Wire
TransCelerate BioPharma’s SQT Initiative Reaches Target Outcomesmembers that have joined since the inception of TransCelerate include Allergan,
TransCelerate BioPharma’s SQT Initiative Reaches Target Outcomes
Business Wire / Posted 6 days ago
members that have joined since the inception of TransCelerate include Allergan, Inc., Amgen, Astellas Pharma Inc., EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Merck & Co., Inc., Novo Nordisk, Shionogi & Co., Ltd... Read more
8d
FOX Business
5 Companies We'd Buy and Hold for the Next 20 Yearsnext couple of decades, spending on diabetes therapies is likely to be massive.
5 Companies We'd Buy and Hold for the Next 20 Years
FOX Business / Posted 8 days ago
next couple of decades, spending on diabetes therapies is likely to be massive. If so, then diabetes market-share leader Novo Nordisk may be one of the best healthcare stocks to stash away in long-terml portfolios. Unlike Eli Lilly & Co., Novo... Read more
8d
FOX Business
5 Companies We'd Buy and Hold for the Next 20 Yearsnext couple of decades, spending on diabetes therapies is likely to be massive.
5 Companies We'd Buy and Hold for the Next 20 Years
FOX Business / Posted 8 days ago
next couple of decades, spending on diabetes therapies is likely to be massive. If so, then diabetes market-share leader Novo Nordisk may be one of the best healthcare stocks to stash away in long-terml portfolios. Unlike Eli Lilly & Co., Novo... Read more
9d
iol.co.za
Can a group of doctors keep an $8bn secret?arrangement, the American Diabetes Association let hundreds, if not thousands,
Can a group of doctors keep an $8bn secret?
iol.co.za / Posted 9 days ago
arrangement, the American Diabetes Association let hundreds, if not thousands, of in-person attendees see new data on Novo Nordisk A/S’s blockbuster diabetes treatment Victoza more than an hour before its official release to the public and the... Read more
12d
Fortune
Why This Pharma Giant Lost $8 Billion in Market Cap This WeekShares of Danish pharma titan Novo Nordisk nvo have fallen nearly 7% so far thi
Why This Pharma Giant Lost $8 Billion in Market Cap This Week
Fortune / Posted 12 days ago
Shares of Danish pharma titan Novo Nordisk nvo have fallen nearly 7% so far this week despite new data showing that one of its core diabetes drugs cuts patients’ risk of heart attacks, strokes, and death. Novo presented findings at the American... Read more
12d
News-Medical-Net
New online Hypo Hub may help diabetic patients better understand signs, long term impact of hypossupport the theme of this year’s Diabetes Week (12–18 June 2016), Setting the r
New online Hypo Hub may help diabetic patients better understand signs, long term impact of hypos
News-Medical-Net / Posted 12 days ago
support the theme of this year’s Diabetes Week (12–18 June 2016), Setting the record straight, leading diabetes company, Novo Nordisk, is launching a new online information resource, Hypo Hub, to provide practical information and guidance for... Read more
14d
CNET
Doctors asked not to tweet confidential information worth $8B at conference tweet it anywaythem doctors, were there to listen to data about a new diabetes drug called Vic
Doctors asked not to tweet confidential information worth $8B at conference tweet it anyway
CNET / Posted 14 days ago
them doctors, were there to listen to data about a new diabetes drug called Victoza. It's manufactured by Danish company Novo Nordisk. Rumors suggested Victoza might be a remarkable breakthrough. But such was the timing of this conference that... Read more
14d
New Bern Sun Journal
Chef teaches healthy cookingwas selected among other groups to receive a grant,” Nuckolls said of how the g
Chef teaches healthy cooking
New Bern Sun Journal / Posted 14 days ago
was selected among other groups to receive a grant,” Nuckolls said of how the group brought in Aikens. The grant, from Novo Nordisk Pharmaceuticals, was awarded because of the high ratings CCHC’s diabetic patients have regarding sugar... Read more
14d
The Morning Call
Can a bunch of doctors keep an $8 billion secret? Not on Twitterarrangement, the American Diabetes Association let hundreds, if not thousands,
Can a bunch of doctors keep an $8 billion secret? Not on Twitter
The Morning Call / Posted 14 days ago
arrangement, the American Diabetes Association let hundreds, if not thousands, of in-person attendees see new data on Novo Nordisk's blockbuster diabetes treatment Victoza more than an hour before its official release to the public and the... Read more
14d
Business Wire
Global Insulin Delivery Device (Insulin Pen, Insulin Syringe, Insulin Pump and Others) Market 2016of the market in the region. Some of the key companies operating in the global
Global Insulin Delivery Device (Insulin Pen, Insulin Syringe, Insulin Pump and Others) Market 2016
Business Wire / Posted 14 days ago
of the market in the region. Some of the key companies operating in the global insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton,... Read more
16d
The Economic Times
Janus’s Health and Fitness ETF gives a heavy weight to Nikea single theme like this. However, the top holdings in these particular ETFs ap
Janus’s Health and Fitness ETF gives a heavy weight to Nike
The Economic Times / Posted 16 days ago
a single theme like this. However, the top holdings in these particular ETFs appear, well, downright obese. Insulin maker Novo Nordisk and dialysis-systems company Fresenius make up about 39% of the Obesity ETF.: About 41% of the Long-Term Care... Read more
16d
Business Standard India
Merck, Pfizer double size of diabetes study to catch rivalsreduced the risk of heart attacks, strokes and deaths by 14 per cent in a study
Merck, Pfizer double size of diabetes study to catch rivals
Business Standard India / Posted 16 days ago
reduced the risk of heart attacks, strokes and deaths by 14 per cent in a study, the first to show such a benefit. Novo Nordisk A/S said in March that its Victoza injections have a similar benefit. The details of that study, called Leader,... Read more
16d
Fortune
IBM and American Diabetes Association Want to Transform the Future of Diabetescan output individualized ranking of diabetes risk factors for patients. IBM is
IBM and American Diabetes Association Want to Transform the Future of Diabetes
Fortune / Posted 16 days ago
can output individualized ranking of diabetes risk factors for patients. IBM is also working with both Medtronic MDT and Novo Nordisk NVO to create innovative diabetes solutions using Watson’s expertise, including the final beta testing of... Read more
18d
The News & Observer
Richard Burr for vice president? Report says Trump is considering him10, 2016 5:23 PM Sen. Richard Burr speaks during a Novo Nordisk groundbreaki
Richard Burr for vice president? Report says Trump is considering him
The News & Observer / Posted 18 days ago
10, 2016 5:23 PM Sen. Richard Burr speaks during a Novo Nordisk groundbreaking ceremony Monday, March 28, 2016 in Clayton, N.C. Jill... Read more
19d
Fortune
Wall Street ‘Obesity’ Fund Could Make Your Wallet Fatteran index designed by a different firm. The top holding in the Obesity ETF, acc
Wall Street ‘Obesity’ Fund Could Make Your Wallet Fatter
Fortune / Posted 19 days ago
an index designed by a different firm. The top holding in the Obesity ETF, accounting for nearly 20% of its portfolio, is Novo Nordisk nvo, a Danish pharmaceutical company specializing in treatments for diabetes, a disease associated with obesity.... Read more
19d
examiner.com
June is Men's Health Month: Manage Type 2 diabetesI made those changes and once I made those changes, I wanted to do something to
June is Men's Health Month: Manage Type 2 diabetes
examiner.com / Posted 19 days ago
I made those changes and once I made those changes, I wanted to do something to educate people. So the relationship with Novo Nordisk was very important to me. Watch the entire Video. Type 2 diabetes is manageable. Men living with Type 2... Read more
19d
The Globe and Mail
Janus Capital goes overweight with new obesity ETFa single theme like this. However, the top holdings in these particular ETFs ap
Janus Capital goes overweight with new obesity ETF
The Globe and Mail / Posted 19 days ago
a single theme like this. However, the top holdings in these particular ETFs appear, well, downright obese. Insulin maker Novo Nordisk and dialysis-systems company Fresenius make up about 39 per cent of the Obesity ETF. About 41 per cent of the... Read more
19d
NJ Biz
NJBIZ General Counsel of the Year winners namedAhmed-Fakhry James Hetzel Company: Hackensack University Medical Center Mich
NJBIZ General Counsel of the Year winners named
NJ Biz / Posted 19 days ago
Ahmed-Fakhry James Hetzel Company: Hackensack University Medical Center Michael Jardim Dana McMahon Company: Novo Nordisk Inc. Jeff Sipos Company: ProSight Specialty Insurance Iveta Wentink William N. Farran Company: Innophos... Read more
19d
iol.co.za
Diabetes: How we can stop the epidemicmonth. Companies operating in the medical fraternity are also doing their bit.
Diabetes: How we can stop the epidemic
iol.co.za / Posted 19 days ago
month. Companies operating in the medical fraternity are also doing their bit. Earlier this month, pharmaceutical company Novo Nordisk held the first New Generation Insulin Summit in Cape Town, where local and international diabetes experts shared... Read more
20d
The Globe and Mail
Three top stock picks from Liberty International’s David Driscollshould continue and help move the stock price higher in the coming years. Last
Three top stock picks from Liberty International’s David Driscoll
The Globe and Mail / Posted 20 days ago
should continue and help move the stock price higher in the coming years. Last purchase: May 19, 2016 at $87.23 (U.S.). Novo Nordisk NV (NOVOB DC) Novo Norisk is the leading global insulin maker that is also making breakthroughs with new types... Read more
20d
MedCity News
MedCity CONVERGE Keynotes Focus on Artificial Intelligence, Big Data Platforms and Value in Diabetes CareBird rate & save $200 Establishing Value in Diabetes Care Todd M. Hobbs, M.D.
MedCity CONVERGE Keynotes Focus on Artificial Intelligence, Big Data Platforms and Value in Diabetes Care
MedCity News / Posted 20 days ago
Bird rate & save $200 Establishing Value in Diabetes Care Todd M. Hobbs, M.D., Chief Medical Officer, North America, Novo Nordisk will discuss the need for pharmaceutical manufacturers to establish the value of medical innovations, what... Read more
21d
FOX News
FDA staff question utility of Sanofi diabetes drugsbut typically does so. Lixisenatide belongs to a class of diabetes treatments
FDA staff question utility of Sanofi diabetes drugs
FOX News / Posted 21 days ago
but typically does so. Lixisenatide belongs to a class of diabetes treatments called GLP-1 agonists that also includes Novo Nordisk A/S' Victoza and Bristol-Myers Squibb Co and AstraZeneca's Byetta and Bydureon. On May 24 the committee will... Read more
22d
Business Wire
Chase Pharmaceuticals Continues to Build Its Senior Leadership Team with Appointment of Two Healthcare Industry Veteransworldwide approvals in 2015 alone. Previously, Gary’s experience includes signi
Chase Pharmaceuticals Continues to Build Its Senior Leadership Team with Appointment of Two Healthcare Industry Veterans
Business Wire / Posted 22 days ago
worldwide approvals in 2015 alone. Previously, Gary’s experience includes significant operational roles at Amgen, Roche, Novo Nordisk and Baxter. Gary’s knowledge in navigating regulatory process with major health authorities including FDA and... Read more
23d
York Daily Record
Moving Up for June 5, 2016Clements, senior producer for MAKE Films, has produced strategic multimedia con
Moving Up for June 5, 2016
York Daily Record / Posted 23 days ago
Clements, senior producer for MAKE Films, has produced strategic multimedia content for the Hershey Company, Sprout!, Novo Nordisk, Cisco and Armstrong and others. (Photo: Submitted) Buchart Horn Inc. is pleased to announce its recent hire of... Read more
26d
Business Standard India
Markets likely to open positive; US jobs data eyedsedan. For Dr Reddy’s Laboratories, the desire to become an innovation-led pha
Markets likely to open positive; US jobs data eyed
Business Standard India / Posted 26 days ago
sedan. For Dr Reddy’s Laboratories, the desire to become an innovation-led pharmaceutical company is not something new: when it out-licensed two anti-diabetes molecules to Novo Nordisk way back in the 1990s, it became the first company t... Read more
16 related stories
26d
Business Standard India
Dr Reddy's re-draws new drug planbecome an innovation-led pharmaceutical company is not something new: when it o
Dr Reddy's re-draws new drug plan
Business Standard India / Posted 26 days ago
become an innovation-led pharmaceutical company is not something new: when it out-licensed two anti-diabetes molecules to Novo Nordisk way back in the 1990s, it became the first company to do so. While Balaglitazar, named after God Balaji, was an... Read more
26d
Business Standard India
Dr Reddy's plans a shift in growth planbecome an innovation-led pharmaceutical company is not something new: when it o
Dr Reddy's plans a shift in growth plan
Business Standard India / Posted 26 days ago
become an innovation-led pharmaceutical company is not something new: when it out-licensed two anti-diabetes molecules to Novo Nordisk way back in the 199s, it became the first company to do so.. While Balaglitazar, named after God Balaji, was an... Read more
28d
Business Standard India
We can be very aggressive in US, EU with biosimilars: Kiran Mazumdar-ShawWe’ve announced with Lab PiSA that we are entering the US market. We also know
We can be very aggressive in US, EU with biosimilars: Kiran Mazumdar-Shaw
Business Standard India / Posted 28 days ago
We’ve announced with Lab PiSA that we are entering the US market. We also know that insulin is an old product, Eli Lilly or Novo Nordisk are not promoting insulin in a big way because they’re promoting analog. They want to cannibalise insulins with... Read more
29d
Business Standard India
We can be very aggressive when we get into US, EU market with our Biosimilars: Kiran Mazumdar Shawhave announced with La Pisa that we are entering the US market. We also know th
We can be very aggressive when we get into US, EU market with our Biosimilars: Kiran Mazumdar Shaw
Business Standard India / Posted 29 days ago
have announced with La Pisa that we are entering the US market. We also know that insulin is an old product, Eli Lilly or Novo Nordisk are not promoting insulin in a big way because they are promoting analog. They want to cannibalise insulins with... Read more
30d
The Auto Channel
"What They're Saying" from the 100th Running of the Indianapolis 500KIMBALL (No. 42 Tresiba Chip Ganassi Racing Chevrolet): "Well, we went through
"What They're Saying" from the 100th Running of the Indianapolis 500
The Auto Channel / Posted 30 days ago
KIMBALL (No. 42 Tresiba Chip Ganassi Racing Chevrolet): "Well, we went through quite a lot with the 42 car. The Novo Nordisk Team and Chip Ganassi Racing never give up. I hit a really big piece of debris. It actually got lodged in the... Read more
614 related stories
1m
Los Angeles Times
Californian Charlie Kimball seeks first Indianapolis 500 winin the 33-car field Sunday. Kimball, 31, has Type 1 diabetes, and he depends o
Californian Charlie Kimball seeks first Indianapolis 500 win
Los Angeles Times / Posted a month ago
in the 33-car field Sunday. Kimball, 31, has Type 1 diabetes, and he depends on insulin made from his primary sponsor, Novo Nordisk, a Danish pharmaceutical company. His car is equipped with a continuous glucose monitor. The newest version of... Read more
m
AllAfrica.com
MEC Qedani Mahlangu - Gauteng Health Prov Budget Vote 2016strengths stems from the fact that the consultants work in the unit 24 hours a
MEC Qedani Mahlangu - Gauteng Health Prov Budget Vote 2016
AllAfrica.com / Posted 1 months ago
strengths stems from the fact that the consultants work in the unit 24 hours a day, 7 days a week. Another initiative! Novo Nordisk International and South Africa donated R1 million towards the first bi-confocal camera for the detection of... Read more
m
Japan Today
Call for gastric surgery to be standard diabetes treatment ‹ Japan Todaymany cases this would lead to patients being able to give up or significantly r
Call for gastric surgery to be standard diabetes treatment ‹ Japan Today
Japan Today / Posted 1 months ago
many cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world’s leading suppliers of insulin and other diabetes drugs. Nick Finer, a... Read more
5 related stories

People in this news